Farokhnia M, Azarkolah A, Adinehfar F, Khodaie-Ardakani M-R, Hosseini S-M-R, Yekehtaz H, Tabrizi M, Rezaei F, Salehi B, Sadeghi S-M-H, Moghadam M, Gharibi F, Mirshafiee O:, Akhondzadeh S: N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study
Wegovy pill (oral semaglutide) and Foundayo (orforglipron) are the first GLP-1 treatments available in a pill form
And the evidence gap on BPC-157 is real
Although overweight is not the primary driver of the disease in type 1 diabetes, it may contribute to further beta-cell loss
Semaglutide the Surprising New Anti-Fibrosis Drug kayleyusher Feb 9 7 min read Updated: Apr 10 Disclaimer: The information provided in this blog in not intended to be medical advice